Composition for treating rheumatoid arthritis containing mesenchymal stem cells derived from patient joint fluid

摘要

The present invention relates to a pharmaceutical composition for the treatment or prevention of arthritis comprising mesenchymal stem cells derived from joint fluid of an individual with rheumatoid arthritis, and in particular, a composition comprising mesenchymal stem cells derived from joint fluid of an individual suffering from early arthritis has an effect on treating or preventing arthritis Is excellent. In addition, the composition of the present invention has superior arthritis treatment effect when administered to an individual with early arthritis than when administered to an individual with end-stage arthritis.